201 related articles for article (PubMed ID: 18647805)
1. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome.
Tasali E; Van Cauter E; Hoffman L; Ehrmann DA
J Clin Endocrinol Metab; 2008 Oct; 93(10):3878-84. PubMed ID: 18647805
[TBL] [Abstract][Full Text] [Related]
2. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.
Tasali E; Van Cauter E; Ehrmann DA
J Clin Endocrinol Metab; 2006 Jan; 91(1):36-42. PubMed ID: 16219719
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.
Vgontzas AN; Legro RS; Bixler EO; Grayev A; Kales A; Chrousos GP
J Clin Endocrinol Metab; 2001 Feb; 86(2):517-20. PubMed ID: 11158002
[TBL] [Abstract][Full Text] [Related]
4. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
Stovall DW; Bailey AP; Pastore LM
J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.
Shalitin S; Deutsch V; Tauman R
J Endocrinol Invest; 2018 Aug; 41(8):969-975. PubMed ID: 29305826
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
7. Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea.
Ehrmann DA
Steroids; 2012 Mar; 77(4):290-4. PubMed ID: 22178788
[TBL] [Abstract][Full Text] [Related]
8. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
Kurioka H; Takahashi K; Miyazaki K
Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
[TBL] [Abstract][Full Text] [Related]
9. Using simple clinical measures to predict insulin resistance or hyperglycemia in girls with polycystic ovarian syndrome.
Cree-Green M; Cai N; Thurston JE; Coe GV; Newnes L; Garcia-Reyes Y; Baumgartner AD; Pyle L; Nadeau KJ
Pediatr Diabetes; 2018 Dec; 19(8):1370-1378. PubMed ID: 30246333
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
Legro RS; Kunselman AR; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
12. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome.
Tasali E; Chapotot F; Leproult R; Whitmore H; Ehrmann DA
J Clin Endocrinol Metab; 2011 Feb; 96(2):365-74. PubMed ID: 21123449
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and endocrine status associate with obstructive sleep apnea risk among patients with polycystic ovary syndrome.
Christ JP; Shinkai K; Corley J; Pasch L; Cedars MI; Huddleston HG
J Clin Sleep Med; 2024 Jun; 20(6):871-877. PubMed ID: 38217476
[TBL] [Abstract][Full Text] [Related]
14. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.
Mokhlesi B; Scoccia B; Mazzone T; Sam S
Fertil Steril; 2012 Mar; 97(3):786-91. PubMed ID: 22264851
[TBL] [Abstract][Full Text] [Related]
15. Metabolic alterations in adolescents with obstructive sleep apnea.
Bhushan B; Ayub B; Loghmanee DA; Billings KR
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2368-73. PubMed ID: 26581829
[TBL] [Abstract][Full Text] [Related]
16. Independent association of vitamin D and insulin resistance in obstructive sleep apnea.
Fan Z; Cao B; Long H; Feng L; Li Q; Zhang Y; Li T
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):319-323. PubMed ID: 31759518
[TBL] [Abstract][Full Text] [Related]
17. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
[TBL] [Abstract][Full Text] [Related]
18. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism.
Luque-Ramírez M; Alpañés M; Escobar-Morreale HF
Fertil Steril; 2010 Nov; 94(6):2214-21. PubMed ID: 20097337
[TBL] [Abstract][Full Text] [Related]
19. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
20. Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology.
Kahal H; Kyrou I; Tahrani AA; Randeva HS
Clin Endocrinol (Oxf); 2017 Oct; 87(4):313-319. PubMed ID: 28640938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
